+30.4%
GSK vs PODD
-57.0%
+87.5%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PODD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -2.1% | +0.1% | -1.7% |
| 7D | -1.8% | +1.6% | -3.4% | -2.0% |
| 30D | -2.2% | +10.7% | -12.8% | -3.1% |
| 3M | -1.8% | +0.7% | -2.5% | -2.3% |
| 6M | -10.6% | -39.3% | +28.7% | -9.0% |
| YTD | +4.4% | -48.1% | +52.5% | +6.2% |
| 1Y | +30.4% | -57.4% | +87.8% | +31.0% |
| All | +30.4% | -57.0% | +87.5% | +31.0% |
Cumulative growth
Daily Returns
Daily percentage return beside PODD.
Daily Out/Under-Performance
Portfolio return minus PODD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PODD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PODD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling